Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 10-Q Report Quarterly Report
  2. 4 Open-market buy Director, President and CEO bought 12,500 shares at $20.23 ($252,875)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. EFFECT Other Notice of Effectiveness
  6. S-8 POS Other Post-effective Amendment
  7. S-8 POS Other Post-effective Amendment
  8. POSASR Other POSASR
  9. S-8 POS Other Post-effective Amendment
  10. S-8 POS Other Post-effective Amendment
  11. S-8 POS Other Post-effective Amendment
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 POS Other Post-effective Amendment
  15. POS AM Other Post-effective Amendment for Registration Statement
  16. 8-A12B/A Other Registration Statement
  17. 10-Q Report Quarterly Report
  18. 144 Insider Sale of Securities
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure

Page 1 of 18 · 353 filings